The FY2025 (Dec) proxy of Iovance Biotherapeutics names 16 peer companies for pay. Pay versus performance data of Iovance Biotherapeutics for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| BridgeBio Pharma | ||
| Revolution Medicines | ||
| Ionis Pharmaceuticals | ||
| Cytokinetics | ||
| Ultragenyx Pharmaceutical | ||
| Arcus Biosciences | ||
| CRISPR Therapeutics AG | ||
| Beam Therapeutics | ||
| Agios Pharmaceuticals | ||
| Denali Therapeutics | ||
| Apellis Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Blueprint Medicines Corp. | Not disclosed | Not disclosed |
| Crinetics Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Immunity Bio, Inc. | Not disclosed | Not disclosed |
| Replimune Group, Inc. | Not disclosed | Not disclosed |
| Xencor | Not disclosed | Not disclosed |
16 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.